Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Coinbase Stock Is Exceptionally Vulnerable, Even as Cryptos Remain Hot

By Thomas Niel, InvestorPlace Contributor

In short, the play with Coinbase stock is clear. Cryptos themselves, rather than stocks with heavy exposure to them, are the better option.

Plug Power Stock Has Plenty More Room to Drop from Here

By Thomas Niel, InvestorPlace Contributor

With speculators no longer buying it on hype alone, continued negative news could sink PLUG stock slowly towards pre-bubble prices.

This Dip in Bitcoin Is Your Chance to Open a Small Position in Crypto

By Thomas Niel, InvestorPlace Contributor

In short, Bitcoin remains a gamble. But, even with talk of regulation sparking a crash, a cautious position in this high-quality crypto, following its recent pullback, is still worth the risk.

Dogecoin May Remain Popular, but Don’t Buy the Pullback

By Thomas Niel, InvestorPlace Contributor

Yet, if you aren't looking to bet on investor psychology, and just want exposure to crypto? Continue sticking with Bitcoin and Ethereum, and pass on Dogecoin.

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel, InvestorPlace Contributor

So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

Load More